biomarkers, tumor

NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer
Sen Yan, Han Zeng, Kaifeng Jin, Fei Shao, Zhaopei Liu, Yuan Chang, Yiwei Wang, Yu Zhu, Zewei Wang, Le Xu, Jiejie Xu

Journal for ImmunoTherapy of Cancer May 2022, 10 (5) e004569; DOI: 10.1136/jitc-2022-004569
Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Jazieh et al
Jieling Zheng, Bin Zhang

Journal for ImmunoTherapy of Cancer May 2022, 10 (5) e004965; DOI: 10.1136/jitc-2022-004965
Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer
Zhenghang Wang, Qi Zhang, Changsong Qi, Yuezong Bai, Feilong Zhao, Hui Chen, Zhongwu Li, Xicheng Wang, Mifen Chen, Jifang Gong, Zhi Peng, Xiaotian Zhang, Jinping Cai, Shiqing Chen, Xiaochen Zhao, Lin Shen, Jian Li

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004703; DOI: 10.1136/jitc-2022-004703
Machine learning for prediction of immunotherapeutic outcome in non-small-cell lung cancer based on circulating cytokine signatures
Feifei Wei, Koichi Azuma, Yoshiro Nakahara, Haruhiro Saito, Norikazu Matsuo, Tomoyuki Tagami, Taku Kouro, Yuka Igarashi, Takaaki Tokito, Terufumi Kato, Tetsuro Kondo, Shuji Murakami, Ryo Usui, Hidetomo Himuro, Shun Horaguchi, Kayoko Tsuji, Kenta Murotani, Tatsuma Ban, Tomohiko Tamura, Yohei Miyagi, Tetsuro Sasada

Journal for ImmunoTherapy of Cancer Jul 2023, 11 (7) e006788; DOI: 10.1136/jitc-2023-006788
Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma
Wenhao Xu, Jiahe Lu, Wang-Rui Liu, Aihetaimujiang Anwaier, Yuhao Wu, Xi Tian, Jia-Qi Su, Yuan-Yuan Qu, Jianfeng Yang, Hailiang Zhang, Dingwei Ye

Journal for ImmunoTherapy of Cancer Dec 2023, 11 (12) e006667; DOI: 10.1136/jitc-2023-006667
Immune microenvironment of basal cell carcinoma and tumor regression following combined PD-1/LAG-3 blockade
Julie Stein Deutsch, Jonathan Lai, Kara M Schenk, Abha Soni, Elizabeth M Will, Logan L Engle, Haiying Xu, Alexandra Ogurtsova, Vrinda Madan, Jennifer K Chong, Daphne Wang, Benjamin F Green, Peter Nguyen, Megan D Schollenberger, Evan J Lipson, Janis M Taube

Journal for ImmunoTherapy of Cancer Dec 2023, 11 (12) e007463; DOI: 10.1136/jitc-2023-007463
Targeting integrin α5 in fibroblasts potentiates colorectal cancer response to PD-L1 blockade by affecting extracellular-matrix deposition
Ling Lu, Yaohui Gao, Dengfeng Huang, Hu Liu, Dingzi Yin, Man Li, Jiayi Zheng, Shufei Wang, Weijun Wu, Li Zhao, Dexi Bi, Youhua Zhang, Feifei Song, Ruting Xie, Jifeng Wang, Huanlong Qin, Qing Wei

Journal for ImmunoTherapy of Cancer Dec 2023, 11 (12) e007447; DOI: 10.1136/jitc-2023-007447
Tumor cell-intrinsic SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway
Xufen Zheng, Yuxiang Luo, Yangjie Xiong, Xiaoxiao Liu, Chunling Zeng, Xiaojing Lu, Xiaofang Wang, Yumei Cheng, Simin Wang, Haoqi Lan, Kai Wang, Zhonghui Weng, Wenbo Bi, Xinxin Gan, Xiaona Jia, Linhui Wang, Yuexiang Wang

Journal for ImmunoTherapy of Cancer Dec 2023, 11 (12) e007678; DOI: 10.1136/jitc-2023-007678
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study
Dominik A Barth, Florian Moik, Sarah Steinlechner, Florian Posch, Marie-Christina Mayer, Amelie M Sandner, Franziska Berton, Verena Schlintl, Lukas Koch, Nikolaus John, Robert Wurm, Martin Pichler, Thomas Bauernhofer, Patrick Reimann, Christoph Wohlkönig, Erika Richtig, Thomas Winder, Matthias Preusser, Philipp J Jost, Cihan Ay, Armin Gerger, Angelika Terbuch, Jakob Michael Riedl

Journal for ImmunoTherapy of Cancer Dec 2023, 11 (12) e007765; DOI: 10.1136/jitc-2023-007765
C-reactive protein impairs immune response of CD8⁺ T cells via FcγRIIb-p38MAPK-ROS axis in multiple myeloma
Jinxing Jiang, Ziyi Peng, Junying Wang, Mengping Chen, Yike Wan, Honghui Huang, Zhiqiang Liu, Jingya Wang, Jian Hou

Journal for ImmunoTherapy of Cancer Oct 2023, 11 (10) e007593; DOI: 10.1136/jitc-2023-007593

Main menu

biomarkers, tumor

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

biomarkers, tumor

Pages